Hectort, you are missing the point and misleading the people. It is the well-recognised fact that Patrys is a company that owns superior patented technologies and has got orphan status of its two products. The company are now focused on product commercialisation which should be No. 1 priority at this stage. In biotech industry, one successfully commercialised product can make a company!
It is a common sense that, without inbound cash flow and cash positive, a company will definitely go out of business even if it has a strong R&D team.
PAB Price at posting:
1.0¢ Sentiment: Buy Disclosure: Held
